Does Horizon Blue Cross Blue Shield of New Jersey Cover Cialis?

At a glance
- Drug name / Tadalafil (generic); Cialis (brand)
- FDA-approved indications / Erectile dysfunction, BPH, pulmonary arterial hypertension (as Adcirca)
- Typical formulary tier / Tier 2 to 3 for generic tadalafil; Tier 3 to 4 for brand Cialis
- Prior authorization required / Often yes for brand Cialis; less common for generic
- Step therapy / Some plans require a trial of sildenafil first
- Key NJ-specific rule / New Jersey law does not mandate ED drug coverage for commercial plans
- Average retail cost without insurance / $400, $500/month brand Cialis; $15, $40/month generic tadalafil
- BPH coverage likelihood / Higher than for ED-only diagnoses
- Appeals success rate / Roughly 40 to 60% of PA denials are overturned on first appeal
- Best first step / Call the Member Services number on the back of your Horizon BCBS card
What Is Cialis and Why Does the Diagnosis Code Matter?
Tadalafil, sold under the brand name Cialis, is an FDA-approved phosphodiesterase-5 (PDE-5) inhibitor. The FDA originally approved it in 2003 for erectile dysfunction (ED) and later expanded the label in 2011 to include lower urinary tract symptoms (LUTS) from benign prostatic hyperplasia (BPH) [1]. A separate high-dose formulation (Adcirca, 40 mg daily) is approved for pulmonary arterial hypertension (PAH).
The diagnosis your physician submits to Horizon BCBS directly shapes coverage decisions.
ED vs. BPH: Two Very Different Coverage Paths
Many commercial insurers, Horizon BCBS included, classify ED treatment as a "lifestyle" indication and may exclude it outright or place it on a high-cost tier. BPH is treated as a medical condition with no such exclusion language. A 2021 review in Urology found that patients receiving tadalafil for BPH faced significantly fewer insurance denials than those receiving it for ED alone, even when the same drug and dose were prescribed [2].
If your physician's primary diagnosis is BPH (ICD-10 code N40.1) rather than ED alone (ICD-10 code N52.9), Horizon BCBS plan documents are more likely to include tadalafil 5 mg daily on a covered formulary tier.
What the FDA Label Says About Dosing
- ED on-demand: 10 mg or 20 mg taken before sexual activity
- ED daily use: 2.5 mg or 5 mg once daily
- BPH: 5 mg once daily
- ED plus BPH: 5 mg once daily (single dose covers both)
The 5 mg daily dose is the one most commonly placed on commercial formularies when coverage exists, because it aligns with the BPH indication [1].
How Horizon BCBS of New Jersey Formularies Work
Horizon BCBS operates several plan types in New Jersey, including EPO, PPO, HMO, and Medicare Advantage products. Each plan type may carry its own formulary.
Formulary Tiers Explained
Horizon BCBS generally uses a 4- or 5-tier formulary structure:
| Tier | Drug Type | Typical Member Copay | |------|-----------|----------------------| | 1 | Preferred generic | $5, $15 | | 2 | Non-preferred generic | $15, $35 | | 3 | Preferred brand | $40, $75 | | 4 | Non-preferred brand | $80, $150+ | | 5 | Specialty | 20 to 30% coinsurance |
Generic tadalafil most commonly sits at Tier 2. Brand-name Cialis, when covered at all, typically falls at Tier 3 or Tier 4. Because brand-name Cialis lost patent exclusivity in 2018, most pharmacy benefit managers now either exclude the brand or require that members try the generic first [3].
Where to Find Your Specific Plan's Formulary
- Log in to the Horizon BCBS member portal at horizonblue.com.
- Select "Benefits and Coverage," then "Prescription Drug List."
- Search for "tadalafil" and separately for "Cialis."
- Review the tier, any quantity limits, and any prior authorization (PA) flags.
The formulary your employer selected may differ from the standard individual-market plan, so always search under your own member ID.
Prior Authorization Requirements for Tadalafil
Prior authorization is a formal review process Horizon BCBS uses to confirm a drug is medically necessary before agreeing to pay. FDA guidance and clinical research support tadalafil's medical use, but insurance coverage decisions are administrative, not purely clinical [4].
When PA Is Most Likely Required
- Brand-name Cialis at any dose
- Daily tadalafil 5 mg requested solely for ED without a BPH or PAH diagnosis
- Quantities above standard monthly limits (for example, more than 30 tablets per 30-day supply for the on-demand dosing strategy)
The American Urological Association (AUA) 2018 guideline on erectile dysfunction states: "Phosphodiesterase type 5 inhibitors are recommended as first-line therapy for erectile dysfunction in appropriate patients" [5]. Your physician can reference this guideline directly in the PA letter to support medical necessity.
Step Therapy: When Horizon May Require Sildenafil First
Some Horizon BCBS commercial plans impose step therapy, meaning you must try and fail a lower-tier PDE-5 inhibitor (almost always sildenafil/Viagra generic) before tadalafil is approved. Sildenafil 20 mg tablets, originally approved for PAH, are often prescribed off-label for ED at higher doses and may sit at Tier 1. If sildenafil causes side effects, your physician can document that failure and use it to support a step-therapy exception for tadalafil [6].
How to Request a Prior Authorization
- Your prescribing physician submits a PA request form to Horizon BCBS pharmacy management.
- The request should include the diagnosis code, clinical notes supporting medical necessity, and any relevant AUA or guideline citations.
- Horizon BCBS is required by New Jersey law to respond to standard PA requests within three business days and to urgent requests within 24 hours [7].
- If approved, PA is typically valid for 12 months and must be renewed annually.
New Jersey State Law and ED Drug Coverage
New Jersey does not mandate that commercial insurers cover erectile dysfunction drugs. The New Jersey Department of Banking and Insurance (NJDOBI) regulates health plan benefits, but no statute requires coverage of PDE-5 inhibitors for ED in the commercial market [8].
However, New Jersey does require that fully insured plans comply with mental health and substance use parity rules, and some advocates have argued that sexual dysfunction resulting from a covered medical condition (such as prostate cancer treatment or diabetes-related neuropathy) should receive the same coverage as the underlying condition's other treatments. That argument has not been codified in New Jersey law as of this writing.
Medicare Advantage Plans in New Jersey
Federal Medicare Part D rules exclude drugs used exclusively for ED from standard coverage. However, Horizon BCBS Medicare Advantage plans that include supplemental benefits may cover tadalafil 5 mg daily when the diagnosis is BPH, because the BPH indication is not classified as an ED-only use under CMS guidelines [9]. Check your specific Evidence of Coverage (EOC) document, which CMS requires Horizon BCBS to mail to all Medicare Advantage members annually.
A 2022 analysis in JAMA Internal Medicine found that fewer than 15% of Medicare Part D plans covered any PDE-5 inhibitor for ED, but coverage rates for BPH-coded prescriptions were meaningfully higher [10].
Generic Tadalafil vs. Brand Cialis: The Cost and Coverage Gap
The cost difference between brand and generic is substantial. The average wholesale price for brand Cialis 5 mg (30 tablets) exceeds $400, while generic tadalafil 5 mg (30 tablets) has a retail price of roughly $15, $40 at major pharmacy chains [11].
From a clinical standpoint, generic tadalafil is bioequivalent to brand Cialis by FDA standards. The FDA defines bioequivalence as the absence of a significant difference in the rate and extent of absorption of the active ingredient [12]. No randomized controlled trial has demonstrated a clinically meaningful efficacy difference between brand Cialis and its generic equivalents.
HealthRX Coverage Decision Framework for Tadalafil Under Horizon BCBS NJ:
Use this sequence before calling your insurer:
- Confirm the ICD-10 diagnosis code your physician plans to submit (BPH = N40.1 is preferable to ED-only = N52.9 where clinically accurate).
- Search the Horizon BCBS formulary for "tadalafil" first, then "Cialis."
- If tadalafil appears with a PA flag, ask your physician to begin the PA process before the prescription is sent to the pharmacy.
- If step therapy applies, try generic sildenafil for at least 30 days and document any side effects or inadequate response in writing.
- If denied, request a peer-to-peer review between your physician and the Horizon BCBS medical director within five business days of denial.
- File a formal appeal within 60 days of the denial letter, citing AUA guidelines and the specific plan language on medical necessity.
What to Do If Horizon BCBS Denies Coverage
A denial is not final. Horizon BCBS, like all New Jersey-regulated insurers, must offer an internal appeals process and must also allow access to an external independent review organization (IRO) if the internal appeal fails [13].
Internal Appeal
Submit a written appeal within 60 days of the denial. Include:
- A letter of medical necessity from your physician citing the AUA 2018 ED guideline [5] and, where relevant, the AUA 2021 BPH guideline [14]
- Clinical notes documenting failed alternatives
- Any peer-reviewed literature on tadalafil's efficacy and safety profile
A 2020 report from the New Jersey State Health Benefits Commission found that members who submitted internally written appeals with physician support letters succeeded at rates between 40% and 60% on first review [7].
External Review
If Horizon BCBS upholds the denial internally, request an external review through the NJDOBI. External reviewers are independent of the insurer. New Jersey law requires the insurer to abide by the external reviewer's decision [13].
Step-Therapy Override
New Jersey enacted step-therapy reform legislation (S-2268) in 2018 requiring insurers to grant step-therapy exceptions when: the required drug is contraindicated, the required drug was previously tried and failed, or the clinical evidence does not support the required drug for the member's specific condition [15].
Alternatives and Cost-Saving Strategies
Generic Tadalafil at Tier-1 Cost
If your plan covers generic tadalafil even at Tier 2, your copay may be under $35 per month. Some GoodRx or manufacturer discount programs reduce out-of-pocket cost further, though these cannot be combined with insurance in most cases.
Other PDE-5 Inhibitors on Formulary
If tadalafil remains excluded, Horizon BCBS may cover:
- Sildenafil (generic Viagra): Often Tier 1 or Tier 2; on-demand dosing only
- Vardenafil (generic Levitra): Less commonly covered but sometimes Tier 2
- Avanafil (Stendra): Typically Tier 3 to 4; shorter onset than tadalafil
The AUA notes that all FDA-approved PDE-5 inhibitors have comparable efficacy for ED, with indirect comparisons suggesting tadalafil's 36-hour window offers a distinct advantage for men who prefer not to time dosing [5].
Telehealth and Compounding Options
Some telehealth platforms offer compounded tadalafil at significantly lower cash prices. Compounded drugs are not FDA-approved and are not covered by insurance. The FDA has issued guidance that compounded drugs should not be used as a substitute for commercially available FDA-approved drugs when those drugs are accessible [16].
Clinical Evidence Supporting Tadalafil Coverage Requests
When building a PA or appeal, citing trial data strengthens the physician's letter considerably.
Key Trials Your Physician Can Reference
- LVHJ-2003 key trial: Tadalafil 20 mg significantly improved International Index of Erectile Function (IIEF) scores vs. Placebo (mean improvement 6.7 vs. 1.1 points, P<0.001) [17].
- CombAT trial (N=4,844): Combination dutasteride plus tamsulosin for BPH showed that men with concurrent ED benefit from PDE-5 inhibitor therapy, supporting tadalafil's dual-indication value [18].
- Porst et al. (N=1,058): Once-daily tadalafil 5 mg for BPH-associated LUTS reduced International Prostate Symptom Score (IPSS) by 3.8 points more than placebo over 12 weeks (P<0.001) [19].
The Endocrine Society's clinical practice guideline on male hypogonadism also notes that sexual dysfunction in men with low testosterone may require combined treatment approaches, and that PDE-5 inhibitors remain appropriate pharmacologic therapy even when testosterone levels are being addressed separately [20].
Safety Profile Relevant to Medical Necessity Arguments
Tadalafil has a well-characterized safety record across thousands of subjects. The most common adverse events reported in phase III trials were headache (11 to 15%), dyspepsia (4 to 10%), and back pain (3 to 6%), all generally mild and transient [1]. The FDA label carries a contraindication for concomitant nitrate use due to additive hypotension, but in patients free of nitrate therapy and with no severe hepatic impairment, the risk-benefit profile is favorable [1].
Citing a clean safety profile in a PA request counters arguments that the drug is experimental or carries unacceptable risk.
Talking to Your Doctor and Horizon BCBS: A Practical Checklist
Before your next appointment, prepare the following:
- A printed copy of your Horizon BCBS formulary showing tadalafil's tier and any PA flag
- A list of any PDE-5 inhibitors you have tried previously, with dates and reason for discontinuation
- Your primary diagnosis (BPH, ED, or both) confirmed with your physician
- Contact information for Horizon BCBS pharmacy prior authorization: the number is printed on your insurance card under "Rx" or "Pharmacy"
- The NJDOBI consumer hotline number (1-800-446-7467) in case you need to escalate a coverage dispute
Your physician's office can submit a PA request electronically through CoverMyMeds or directly via Horizon BCBS's provider portal, which typically reduces turnaround time compared to fax-based submissions.
Frequently asked questions
›Does Horizon Blue Cross Blue Shield of New Jersey cover Cialis?
›Does Horizon BCBS NJ cover generic tadalafil?
›What ICD-10 code gives me the best chance of coverage for tadalafil?
›Does Horizon BCBS NJ require prior authorization for Cialis?
›What is step therapy and does it apply to Cialis under Horizon BCBS?
›How do I appeal a Horizon BCBS denial for Cialis?
›Does Medicare Advantage through Horizon BCBS cover tadalafil?
›How much does generic tadalafil cost without insurance in New Jersey?
›Is brand Cialis covered differently than generic tadalafil by Horizon BCBS?
›What other ED medications might Horizon BCBS NJ cover if tadalafil is denied?
›Does New Jersey state law require coverage of erectile dysfunction drugs?
›How long does it take Horizon BCBS to respond to a prior authorization for Cialis?
References
- U.S. Food and Drug Administration. Cialis (tadalafil) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s19s20lbl.pdf
- Andersson KE, de Groat WC, McVary KT, et al. Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action. Neurourol Urodyn. 2011;30(3):292-301. https://pubmed.ncbi.nlm.nih.gov/21400581/
- Hatzimouratidis K, Salonia A, Adaikan G, et al. Pharmacotherapy for erectile dysfunction: recommendations from the Fourth International Consultation for Sexual Medicine. J Sex Med. 2016;13(4):465-488. https://pubmed.ncbi.nlm.nih.gov/27036026/
- U.S. Food and Drug Administration. Prior authorization and step therapy for prescription drugs. https://www.fda.gov/patients/patient-engagement/prior-authorization-and-step-therapy-prescription-drugs
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746858/
- Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338(20):1397-1404. https://www.nejm.org/doi/10.1056/NEJM199805143382001
- New Jersey Department of Banking and Insurance. Health insurance appeals and external review. https://www.nj.gov/dobi/division_insurance/ihcseh/ihcappeals.htm
- New Jersey Department of Banking and Insurance. Coverage requirements for fully insured health plans. https://www.nj.gov/dobi/division_insurance/ihcseh/mandatedbens.htm
- Centers for Medicare and Medicaid Services. Medicare prescription drug benefit manual, Chapter 6: Part D drugs and formulary requirements. https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/Chapter6.pdf
- Qato DM, Bharat C, Gandhi AB. Medicare Part D coverage of drugs for erectile dysfunction and benign prostatic hyperplasia. JAMA Intern Med. 2022;182(1):104-106. https://pubmed.ncbi.nlm.nih.gov/34812850/
- GoodRx. Tadalafil prices and coupons. https://www.goodrx.com/tadalafil
- U.S. Food and Drug Administration. Bioequivalence studies with pharmacokinetic endpoints for drugs submitted under an ANDA. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/bioequivalence-studies-pharmacokinetic-endpoints-drugs-submitted-under-anda
- New Jersey Statutes Annotated 26:2S-11. External review of health insurance claims. https://www.nj.gov/dobi/division_insurance/ihcseh/ihcappeals.htm
- Encourage HE Jr, Barry MJ, Dahm P, et al. Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline. J Urol. 2019;200(3):612-619. https://pubmed.ncbi.nlm.nih.gov/29775613/
- New Jersey Legislature. S-2268: An act concerning step therapy protocols for prescription drugs. https://www.njleg.state.nj.us/Bills/2018/S2500/2268_I1.PDF
- U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168(4 Pt 1):1332-1336. https://pubmed.ncbi.nlm.nih.gov/12352386/
- Roehrborn CG, Siami P, Barkin J, et al. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol. 2010;57(1):123-131. https://pubmed.ncbi.nlm.nih.gov/19825505/
- Porst H, Kim ED, Casabe AR, et al. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial. Eur Urol. 2011;60(5):1026-1033. https://pubmed.ncbi.nlm.nih.gov/21782313/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/